Literature DB >> 17102831

Eisenmenger syndrome and atrial septal defect: nature or nurture?

Judith Therrien1, Sherryn Rambihar, Bill Newman, Kathy Siminovitch, David Langleben, Gary Webb, John Granton.   

Abstract

BACKGROUND: It has long been debated whether patients with atrial septal defect (ASD) Eisenmenger syndrome have idiopathic pulmonary arterial hypertension with an incidental ASD or severe pulmonary hypertension on the basis of their ASD shunt magnitude alone. HYPOTHESIS: It was hypothesized that if ASD Eisenmenger patients had idiopathic pulmonary arterial hypertension with an incidental ASD, a mutation in the bone morphogenetic protein receptor-2 (BMPR2) would be found in some of these patients. PATIENTS AND METHODS: All adult patients with ASD Eisenmenger syndrome were identified from the databases of two adult congenital cardiac units, and were matched to a control group with similar types of ASDs and no pulmonary hypertension. Gene coding for BMPR2 was examined for mutation using denaturing high-performance liquid chromatography of the entire coding sequence.
RESULTS: Eighteen adult patients with ASD Eisenmenger syndrome and 18 control patients were identified. ASD Eisenmenger patients had significantly larger ASDs than the control patients (3.7+/-1.2 cm versus 1.9+/-0.7 cm, P<0.01). A mutation in BMPR2 was not detected in either group.
CONCLUSION: ASD Eisenmenger syndrome may occur without BMPR2 mutation. Whether shunt magnitude alone or in combination with yet another genetic mutation is responsible for the development of pulmonary hypertension in these patients remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17102831      PMCID: PMC2569052          DOI: 10.1016/s0828-282x(06)70950-3

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  25 in total

Review 1.  CCS Consensus Conference 2001 update: recommendations for the management of adults with congenital heart disease. Part I.

Authors:  J Therrien; A Dore; W Gersony; L Iserin; R Liberthson; F Meijboom; J M Colman; E Oechslin; D Taylor; J Perloff; J Somerville; G D Webb
Journal:  Can J Cardiol       Date:  2001-09       Impact factor: 5.223

2.  ATRIAL SEPTAL DEFECT WITH PULMONARY HYPERTENSION.

Authors:  E Besterman
Journal:  Br Heart J       Date:  1961-09

3.  Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension.

Authors:  H Wilkens; A Guth; J König; N Forestier; B Cremers; B Hennen; M Böhm; G W Sybrecht
Journal:  Circulation       Date:  2001-09-11       Impact factor: 29.690

4.  Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.

Authors:  R C Trembath; J R Thomson; R D Machado; N V Morgan; C Atkinson; I Winship; G Simonneau; N Galie; J E Loyd; M Humbert; W C Nichols; N W Morrell; J Berg; A Manes; J McGaughran; M Pauciulo; L Wheeler
Journal:  N Engl J Med       Date:  2001-08-02       Impact factor: 91.245

5.  Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred.

Authors:  J H Newman; L Wheeler; K B Lane; E Loyd; R Gaddipati; J A Phillips; J E Loyd
Journal:  N Engl J Med       Date:  2001-08-02       Impact factor: 91.245

6.  Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor.

Authors:  Carl Atkinson; Susan Stewart; Paul D Upton; Rajiv Machado; Jennifer R Thomson; Richard C Trembath; Nicholas W Morrell
Journal:  Circulation       Date:  2002-04-09       Impact factor: 29.690

Review 7.  Primary pulmonary hypertension.

Authors:  S P Gaine; L J Rubin
Journal:  Lancet       Date:  1998-08-29       Impact factor: 79.321

8.  BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease.

Authors:  K E Roberts; J J McElroy; W P K Wong; E Yen; A Widlitz; R J Barst; J A Knowles; J H Morse
Journal:  Eur Respir J       Date:  2004-09       Impact factor: 16.671

9.  Sitaxsentan therapy for pulmonary arterial hypertension.

Authors:  Robyn J Barst; David Langleben; Adaani Frost; Evelyn M Horn; Ronald Oudiz; Shelley Shapiro; Vallerie McLaughlin; Nicholas Hill; Victor F Tapson; Ivan M Robbins; Diane Zwicke; Benjamin Duncan; Richard A F Dixon; Lyn R Frumkin
Journal:  Am J Respir Crit Care Med       Date:  2003-11-20       Impact factor: 21.405

Review 10.  Primary pulmonary hypertension: insights into pathogenesis from epidemiology.

Authors:  N Galiè; A Manes; L Uguccioni; F Serafini; M De Rosa; A Branzi; B Magnani
Journal:  Chest       Date:  1998-09       Impact factor: 9.410

View more
  6 in total

1.  Human herpesvirus-8 infection of primary pulmonary microvascular endothelial cells.

Authors:  Todd M Bull; Christina A Meadows; Christopher D Coldren; Mark Moore; Sylk M Sotto-Santiago; Serge P Nana-Sinkam; Thomas B Campbell; Mark W Geraci
Journal:  Am J Respir Cell Mol Biol       Date:  2008-06-27       Impact factor: 6.914

Review 2.  Pathogenic mechanisms of pulmonary arterial hypertension.

Authors:  Stephen Y Chan; Joseph Loscalzo
Journal:  J Mol Cell Cardiol       Date:  2007-09-20       Impact factor: 5.000

3.  Late-Onset Cyanosis and Finger Clubbing in a 37-Year-Old Female with Ebstein's Anomaly and Atrial Septal Defect.

Authors:  Kook-Jin Chun; Dong Cheul Han; Yong Hyun Park; Sang-Kwon Lee
Journal:  Acta Cardiol Sin       Date:  2013-11       Impact factor: 2.672

Review 4.  Pulmonary vascular disease related to hemodynamic stress in the pulmonary circulation.

Authors:  Stephen Y Chan; Joseph Loscalzo
Journal:  Compr Physiol       Date:  2011-01       Impact factor: 9.090

5.  The Efficacy of a Genetic Analysis of the BMPR2 Gene in a Patient with Severe Pulmonary Arterial Hypertension and an Atrial Septal Defect Treated with Bilateral Lung Transplantation.

Authors:  Shunsuke Tatebe; Koichiro Sugimura; Tatsuo Aoki; Saori Yamamoto; Nobuhiro Yaoita; Hideaki Suzuki; Haruka Sato; Katsuya Kozu; Ryo Konno; Kimio Satoh; Koji Fukuda; Osamu Adachi; Ryoko Saito; Norifumi Nakanishi; Hiroko Morisaki; Kotaro Oyama; Yoshikatsu Saiki; Yoshinori Okada; Hiroaki Shimokawa
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271

Review 6.  Pulmonary Arterial Hypertension: Iron Matters.

Authors:  Latha Ramakrishnan; Sofia L Pedersen; Quezia K Toe; Gregory J Quinlan; Stephen J Wort
Journal:  Front Physiol       Date:  2018-05-31       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.